Jazz Pharmaceuticals to acquire Celator for $1.5 billion
31 May 2016 | By Victoria White, Digital Content Producer
The transaction advances Jazz Pharmaceuticals' growth strategy and adds Celator's investigational therapy Vyxeous to the company’s portfolio...